Can virtual reality-based meditation help reduce anxiety and depression in patients newly diagnosed with acute leukemia?

Not Applicable

Completed

• Conditions: Prevention of anxiety and depression during induction chemotherapy in previously untreated patients newly diagnosed with acute leukemia; Mental and Behavioural Disorders

• Registration Number: ISRCTN84842464
• Lead Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36693237 (added 02/05/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-02-12
• Study Start: 2022-06-06
• Last Update Posted: 15 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

1. Newly diagnosed with acute leukemia, including acute myeloid leukemia and acute lymphocytic leukemia
2. No relevant previous treatment
3. Aged 18 years and over
4. Normal cognition and comprehension
5. Karnofsky Performance Status >60

Exclusion Criteria

1. Aggravation in related symptoms, such as severe infection, bleeding, or anemia
2. Complicated with other neoplastic diagnoses
3. In a critical condition
4. Accompanied eye-related diseases
5. Refused participation or participating in other studies

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Anxiety is measured using State Anxiety Inventory at baseline and post-intervention (2 weeks)<br> 2. Depression is measured using the Center for Epidemiological Studies Depression Scale at baseline and post-intervention (2 weeks)<br>

Secondary Outcome Measures

Name	Time	Method
Quality of life is measured using The Functional Assessment of Cancer Therapy-Leukemia Questionnaire at baseline and post-intervention (2 weeks).